NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Blood Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Blood Safety



Blood safety can be evaluated by modeling risks of viral transmission



December 29th, 2005

Recent research from Australia has reported that blood safety can be evaluated by modeling the risks of transfusion transmitted human immunodeficiency virus (HIV), hepatitis B virus (HBV), hepatitis C virus (HCV) and human T lymphotrophic virus (HTLV).

"The risk of transfusion transmitted viral infection is now so low that mathematical modelling is required to estimate the residual risk. The first national viral risk estimates for HBV, HIV and HCV were recently published by the Australian Red Cross Blood Service," wrote C.R. Seed and colleagues, Australian Red Cross Blood Service.

"Using several refinements to the original methodology, as well as an...


Source: Blood Weekly (2005-12-29)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login